The latest financial results for the current quarter have been declared, with a total of 1495 stocks announcing their performance for the period of December 2023. The trend over the last four quarters has shown a positive growth, with 52.0% of companies reporting positive results for the current quarter, followed by 50.0% in September 2023, 47.0% in June 2023, and 48.0% in March 2023.

In terms of market capitalization, large cap companies have shown the highest proportion of positive results at 62.0%, followed by mid cap at 52.0% and small cap at 45.0%. Among the top performers in each category, Punjab National Bank from the public banks sector has emerged as the top result for large cap companies, while Swan Energy from the textile sector has shown outstanding performance for mid cap companies. For small cap companies, Asian Energy from the oil exploration/refineries sector has reported the highest results.

In the last 24 hours, 183 results have been declared, with Lupin emerging as the top performer. This pharmaceutical company has seen a bullish trend since January 2, 2024, with its score increasing from mildly bullish to bullish. The company's financial performance for the quarter of December 2023 has been outstanding, with a score of 37, a slight decrease from 39 in the previous quarter.

Lupin's financials for the quarter have shown significant growth, with its PAT (profit after tax) increasing by 84.2% to Rs 613.12 crore, the highest among all companies. Its net sales have also reached a record high of Rs 5,197.41 crore, while its operating profit to interest ratio and PBDIT (profit before depreciation, interest, and taxes) have also shown the highest results at 14.02 times and Rs 1,037.94 crore respectively. The company's operating profit to net sales ratio has also reached a high of 19.97%, while its PBT (profit before tax) less OI (other income) has grown by 79.5% to Rs 706.73 crore. Lupin's EPS (earnings per share) for the quarter has also shown the highest result at Rs 13.46.

In terms of financial ratios, Lupin has shown a low debt-equity ratio of 0.29 times, the lowest among all companies, and a high debtors turnover ratio of 4.09 times. With such strong financial performance, Lupin is expected to continue its bullish trend in the upcoming results.

Investors can also look forward to the upcoming results of Zydus Lifesciences, Hero MotoCorp, and Emami on February 9, 2024. With the current quarter showing positive results and strong financial performance from top companies, the market is expected to continue its upward trend.